According to Becker’s ASC Review, gastroenterology is heading into 2026 facing major disruption as rising demand collides with operational and financial pressure. Earlier-onset GI cancers are expanding the screening population, driving sustained growth in colonoscopy and endoscopy volumes while increasing case complexity. Practices are managing sicker, higher-acuity patients and greater chronic disease burden, even as staffing shortages persist. Becker’s highlights AI-enabled patient access and automation as essential tools to absorb demand, while procedures continue shifting from hospitals to ASCs. At the same time, tighter reimbursement and evolving payer expectations are forcing GI groups to rethink site-of-care strategy, value-based alignment, and how they demonstrate quality and efficiency.
Keep Reading
Add A Comment